Literature DB >> 21807511

Synthesis and biochemical evaluation of triazole/tetrazole-containing sulfonamides against thrombin and related serine proteases.

Rogelio Siles1, Yuko Kawasaki, Patrick Ross, Ernesto Freire.   

Abstract

A small library of 25 triazole/tetrazole-based sulfonamides have been synthesized and further evaluated for their inhibitory activity against thrombin, trypsin, tryptase and chymase. In general, the triazole-based sulfonamides inhibited thrombin more efficiently than the tetrazole counterparts. Particularly, compound 26 showed strong thrombin inhibition (K(i)=880 nM) and significant selectivity against other human related serine proteases like trypsin (K(i)=729 μM). Thrombin binding affinity of the same compound was determined by ITC and demonstrated that the binding of this new triazole-based scaffold is enthalpically driven, making it a good candidate for further development.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21807511      PMCID: PMC3159800          DOI: 10.1016/j.bmcl.2011.07.023

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  20 in total

Review 1.  Structure-based design of thrombin inhibitors.

Authors:  Roland Pfau
Journal:  Curr Opin Drug Discov Devel       Date:  2003-07

Review 2.  Progress in the development of synthetic thrombin inhibitors as new orally active anticoagulants.

Authors:  Torsten Steinmetzer; Jörg Stürzebecher
Journal:  Curr Med Chem       Date:  2004-09       Impact factor: 4.530

3.  Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 position.

Authors:  T J Tucker; S F Brady; W C Lumma; S D Lewis; S J Gardell; A M Naylor-Olsen; Y Yan; J T Sisko; K J Stauffer; B J Lucas; J J Lynch; J J Cook; M T Stranieri; M A Holahan; E A Lyle; E P Baskin; I W Chen; K B Dancheck; J A Krueger; C M Cooper; J P Vacca
Journal:  J Med Chem       Date:  1998-08-13       Impact factor: 7.446

4.  Deaths: final data for 2008.

Authors:  Arialdi M Miniño; Sherry L Murphy; Jiaquan Xu; Kenneth D Kochanek
Journal:  Natl Vital Stat Rep       Date:  2011-12-07

5.  Preparation of 5-substituted 1H-tetrazoles from nitriles in water.

Authors:  Z P Demko; K B Sharpless
Journal:  J Org Chem       Date:  2001-11-30       Impact factor: 4.354

Review 6.  Old and new anticoagulant drugs: a minireview.

Authors:  Pier Mannuccio Mannucci; Massimo Franchini
Journal:  Ann Med       Date:  2011-01-24       Impact factor: 4.709

Review 7.  Progress in the design of low molecular weight thrombin inhibitors.

Authors:  Stuti Srivastava; Lalit N Goswami; Dinesh K Dikshit
Journal:  Med Res Rev       Date:  2005-01       Impact factor: 12.944

Review 8.  Do enthalpy and entropy distinguish first in class from best in class?

Authors:  Ernesto Freire
Journal:  Drug Discov Today       Date:  2008-08-26       Impact factor: 7.851

9.  Pt(IV)-catalyzed cyclization of arene-alkyne substrates via intramolecular electrophilic hydroarylation.

Authors:  Stefan J Pastine; So Won Youn; Dalibor Sames
Journal:  Org Lett       Date:  2003-04-03       Impact factor: 6.005

10.  Discovery and evaluation of potent P1 aryl heterocycle-based thrombin inhibitors.

Authors:  Mary Beth Young; James C Barrow; Kristen L Glass; George F Lundell; Christina L Newton; Janetta M Pellicore; Kenneth E Rittle; Harold G Selnick; Kenneth J Stauffer; Joseph P Vacca; Peter D Williams; Dennis Bohn; Franklin C Clayton; Jacquelynn J Cook; Julie A Krueger; Lawrence C Kuo; S Dale Lewis; Bobby J Lucas; Daniel R McMasters; Cynthia Miller-Stein; Beth L Pietrak; Audrey A Wallace; Rebecca B White; Bradley Wong; Youwei Yan; Philippe G Nantermet
Journal:  J Med Chem       Date:  2004-06-03       Impact factor: 7.446

View more
  1 in total

1.  Identification of protease inhibitors by a fast fluorimetric assay.

Authors:  Nunzianna Doti; Domenico Raimondo; Marco Sabatella; Menotti Ruvo
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.